美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0054-0370-25	0054-0370	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate	lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825	N/A	ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	20 mg/1	100 CAPSULE in 1 BOTTLE (0054-0370-25)
0054-0374-25	0054-0374	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate	lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825	N/A	ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	60 mg/1	100 CAPSULE in 1 BOTTLE (0054-0374-25)
0054-0372-25	0054-0372	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate	lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825	N/A	ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	40 mg/1	100 CAPSULE in 1 BOTTLE (0054-0372-25)
0054-0375-25	0054-0375	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate	lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825	N/A	ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	70 mg/1	100 CAPSULE in 1 BOTTLE (0054-0375-25)
0054-0373-25	0054-0373	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate	lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825	N/A	ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	50 mg/1	100 CAPSULE in 1 BOTTLE (0054-0373-25)
0054-0371-25	0054-0371	HUMAN PRESCRIPTION DRUG	Lisdexamfetamine Dimesylate	lisdexamfetamine dimesylate	CAPSULE	ORAL	20230825	N/A	ANDA	ANDA202827	Hikma Pharmaceuticals USA Inc.	LISDEXAMFETAMINE DIMESYLATE	30 mg/1	100 CAPSULE in 1 BOTTLE (0054-0371-25)